Nationwide nonprofit eliminating cancer; publishes leading journals.
The Department of Health and Human Services has appointed permanent directors for three FDA centres — drugs, vaccines and tobacco products — ending months of acting leadership and departures. Michael Davis will lead the drugs centre; Karim Mikhail will head vaccines; Bret Koplow will run tobacco. HHS also created an AI and technology oversight post.
The FDA has approved bemotrizinol (BEMT) for over‑the‑counter sunscreens, marking a modernization in U.S. UV protection. The ingredient absorbs both UVA and UVB rays, is photostable, and will debut as Parsol Shield before broader market adoption after an 18‑month exclusivity period. Industry and dermatology experts say the move could improve protection and user experience, though rollout and formulation timelines remain.
Five or more sunburns raise melanoma risk by up to 80%, with age and burn severity shaping outcomes. Experts urge daily sunscreen and preventive care as cases rise across the United States.
Vivani Medical is developing a long-acting semaglutide implant to deliver GLP-1 therapy over months, potentially replacing injections. Novo Nordisk is evaluating the device to improve adherence and reduce weight regain, but regulatory and cost questions remain as trials proceed.
Federal SNAP reform has tightened eligibility and shifted costs to states, triggering a sharp drop in participation and putting pressure on food banks. Arizona records the largest decline, with state processes becoming more burdensome and delivery times longer as programs adjust. Projections warn of continued reductions without congressional action.
Medicaid work-reporting requirements are rolling out in multiple states, with Nebraska initiating deductions for enrollees who don’t report 80 hours of community engagement. Officials warn the rollout could trigger a nationwide coverage risk, while providers and patient groups push for broader medical exemptions amid mounting opposition to the policy.
Sims, eight years after a melanoma diagnosis, is warning that tanning is surging again among young people online. Experts say tanning beds dramatically raise melanoma risk, with DNA mutations more likely in users. Reports show 100,000+ melanomas expected in 2026; influencers promote tanning, while dermatologists stress there is no safe tan.
Athletes and patients have urged Downing Street to appoint a national brain cancer lead and boost research funding. The Rare Cancers Bill is seen as a step forward but not enough, with calls for faster action in light of Commonwealth Games coverage and ongoing treatment campaigns.
Sydney Towle, a 26-year-old influencer known for documenting her battle with cholangiocarcinoma on TikTok, has died after a three-year fight. Family posted that she died peacefully in hospice care. Her journey drew a large online following and spotlighted the realities of cancer among young people.
The FDA has approved daraxonrasib (Rasonque), a once-daily pill from Revolution Medicines, for adults with metastatic pancreatic cancer who have received prior therapy or cannot take combination chemotherapy. A 500‑patient trial has shown median survival of 13.2 months versus 6.7 months for chemotherapy; a 30‑day supply will cost about $39,800 and expanded access has already treated thousands.
GLP-1 medications are being increasingly prescribed off-label to children aged 8–11 in the US, despite no FDA approval for under-12s. A NYU Langone study shows a dramatic rise in June 2026, while experts warn about long-term effects and the broader obesity crisis.